Polyneuropathy in Cerebrotendinous Xanthomatosis: Diagnostic Challenges and Potential for Therapeutic Intervention

Cerebrotendinous xanthomatosis (CTX) is a rare metabolic disorder caused by mutations in the <i>CYP27A1</i> gene, leading to cholestanol accumulation in various tissues, including peripheral nerves. Polyneuropathy is an underrecognized feature with considerable variability in clinical pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonio Edvan Camelo-Filho, Pedro Lucas Grangeiro Sá Barreto Lima, Francisco Luciano Honório Barreto Cavalcante, Oliver Reiks Miyajima, Carolina Figueiredo Santos, Rodrigo Fagundes da Rosa, André Luiz Santos Pessoa, Pedro Braga-Neto, Paulo Ribeiro Nóbrega
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/14/11/1159
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846154113684865024
author Antonio Edvan Camelo-Filho
Pedro Lucas Grangeiro Sá Barreto Lima
Francisco Luciano Honório Barreto Cavalcante
Oliver Reiks Miyajima
Carolina Figueiredo Santos
Rodrigo Fagundes da Rosa
André Luiz Santos Pessoa
Pedro Braga-Neto
Paulo Ribeiro Nóbrega
author_facet Antonio Edvan Camelo-Filho
Pedro Lucas Grangeiro Sá Barreto Lima
Francisco Luciano Honório Barreto Cavalcante
Oliver Reiks Miyajima
Carolina Figueiredo Santos
Rodrigo Fagundes da Rosa
André Luiz Santos Pessoa
Pedro Braga-Neto
Paulo Ribeiro Nóbrega
author_sort Antonio Edvan Camelo-Filho
collection DOAJ
description Cerebrotendinous xanthomatosis (CTX) is a rare metabolic disorder caused by mutations in the <i>CYP27A1</i> gene, leading to cholestanol accumulation in various tissues, including peripheral nerves. Polyneuropathy is an underrecognized feature with considerable variability in clinical presentation and neurophysiological findings in CTX. This review assesses the prevalence, clinical manifestations, and diagnostic methodologies of polyneuropathy in CTX, exploring its underlying mechanisms and potential treatment outcomes. A literature review was conducted using PubMed, Embase, and the Virtual Health Library databases with search terms related to CTX and polyneuropathy. A total of 892 articles were initially identified, with 59 selected for in-depth analysis. The review focused on studies examining peripheral nerve involvement in CTX, including nerve conduction studies, electromyography, and nerve ultrasound. Polyneuropathy in CTX was observed in 50% to 77.7% of patients across multiple case series. Neurophysiological findings varied, with reports of axonal, demyelinating, and mixed polyneuropathies. Clinical presentation included lower limb atrophy, pes cavus, and distal weakness, with sensory symptoms less frequently reported. Treatment with chenodeoxycholic acid (CDCA) showed potential in improving nerve conduction parameters, although the response was variable and dependent on the timing of intervention. Polyneuropathy in CTX presents significant diagnostic challenges due to its heterogeneous presentation and varying neurophysiological findings. Early recognition and intervention are crucial for improving patient outcomes. Peripheral nerve ultrasound is a promising diagnostic tool, complementing traditional neurophysiological assessments. Further research is needed to standardize protocols and explore the full therapeutic potential of CDCA in managing CTX-related polyneuropathy.
format Article
id doaj-art-a242ae5464394c13abe6f2b550a213e3
institution Kabale University
issn 2076-3425
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj-art-a242ae5464394c13abe6f2b550a213e32024-11-26T17:55:14ZengMDPI AGBrain Sciences2076-34252024-11-011411115910.3390/brainsci14111159Polyneuropathy in Cerebrotendinous Xanthomatosis: Diagnostic Challenges and Potential for Therapeutic InterventionAntonio Edvan Camelo-Filho0Pedro Lucas Grangeiro Sá Barreto Lima1Francisco Luciano Honório Barreto Cavalcante2Oliver Reiks Miyajima3Carolina Figueiredo Santos4Rodrigo Fagundes da Rosa5André Luiz Santos Pessoa6Pedro Braga-Neto7Paulo Ribeiro Nóbrega8Division of Neurology, Department of Clinical Medicine, Federal University of Ceará, Fortaleza 60430-372, Ceara, BrazilDivision of Neurology, Department of Clinical Medicine, Federal University of Ceará, Fortaleza 60430-372, Ceara, BrazilDivision of Neurology, Department of Clinical Medicine, Federal University of Ceará, Fortaleza 60430-372, Ceara, BrazilCenter of Health Sciences, State University of Ceara, Fortaleza 60714-903, Ceara, BrazilCurso de Medicina, Universidade de Fortaleza, Fortaleza 60150-160, Ceara, BrazilDivision of Neurology, Department of Clinical Medicine, Federal University of Ceará, Fortaleza 60430-372, Ceara, BrazilDivision of Neurology, Department of Clinical Medicine, Federal University of Ceará, Fortaleza 60430-372, Ceara, BrazilDivision of Neurology, Department of Clinical Medicine, Federal University of Ceará, Fortaleza 60430-372, Ceara, BrazilDivision of Neurology, Department of Clinical Medicine, Federal University of Ceará, Fortaleza 60430-372, Ceara, BrazilCerebrotendinous xanthomatosis (CTX) is a rare metabolic disorder caused by mutations in the <i>CYP27A1</i> gene, leading to cholestanol accumulation in various tissues, including peripheral nerves. Polyneuropathy is an underrecognized feature with considerable variability in clinical presentation and neurophysiological findings in CTX. This review assesses the prevalence, clinical manifestations, and diagnostic methodologies of polyneuropathy in CTX, exploring its underlying mechanisms and potential treatment outcomes. A literature review was conducted using PubMed, Embase, and the Virtual Health Library databases with search terms related to CTX and polyneuropathy. A total of 892 articles were initially identified, with 59 selected for in-depth analysis. The review focused on studies examining peripheral nerve involvement in CTX, including nerve conduction studies, electromyography, and nerve ultrasound. Polyneuropathy in CTX was observed in 50% to 77.7% of patients across multiple case series. Neurophysiological findings varied, with reports of axonal, demyelinating, and mixed polyneuropathies. Clinical presentation included lower limb atrophy, pes cavus, and distal weakness, with sensory symptoms less frequently reported. Treatment with chenodeoxycholic acid (CDCA) showed potential in improving nerve conduction parameters, although the response was variable and dependent on the timing of intervention. Polyneuropathy in CTX presents significant diagnostic challenges due to its heterogeneous presentation and varying neurophysiological findings. Early recognition and intervention are crucial for improving patient outcomes. Peripheral nerve ultrasound is a promising diagnostic tool, complementing traditional neurophysiological assessments. Further research is needed to standardize protocols and explore the full therapeutic potential of CDCA in managing CTX-related polyneuropathy.https://www.mdpi.com/2076-3425/14/11/1159cerebrotendineous xanthomatosispolyneuropathyEMGnerve ultrasound
spellingShingle Antonio Edvan Camelo-Filho
Pedro Lucas Grangeiro Sá Barreto Lima
Francisco Luciano Honório Barreto Cavalcante
Oliver Reiks Miyajima
Carolina Figueiredo Santos
Rodrigo Fagundes da Rosa
André Luiz Santos Pessoa
Pedro Braga-Neto
Paulo Ribeiro Nóbrega
Polyneuropathy in Cerebrotendinous Xanthomatosis: Diagnostic Challenges and Potential for Therapeutic Intervention
Brain Sciences
cerebrotendineous xanthomatosis
polyneuropathy
EMG
nerve ultrasound
title Polyneuropathy in Cerebrotendinous Xanthomatosis: Diagnostic Challenges and Potential for Therapeutic Intervention
title_full Polyneuropathy in Cerebrotendinous Xanthomatosis: Diagnostic Challenges and Potential for Therapeutic Intervention
title_fullStr Polyneuropathy in Cerebrotendinous Xanthomatosis: Diagnostic Challenges and Potential for Therapeutic Intervention
title_full_unstemmed Polyneuropathy in Cerebrotendinous Xanthomatosis: Diagnostic Challenges and Potential for Therapeutic Intervention
title_short Polyneuropathy in Cerebrotendinous Xanthomatosis: Diagnostic Challenges and Potential for Therapeutic Intervention
title_sort polyneuropathy in cerebrotendinous xanthomatosis diagnostic challenges and potential for therapeutic intervention
topic cerebrotendineous xanthomatosis
polyneuropathy
EMG
nerve ultrasound
url https://www.mdpi.com/2076-3425/14/11/1159
work_keys_str_mv AT antonioedvancamelofilho polyneuropathyincerebrotendinousxanthomatosisdiagnosticchallengesandpotentialfortherapeuticintervention
AT pedrolucasgrangeirosabarretolima polyneuropathyincerebrotendinousxanthomatosisdiagnosticchallengesandpotentialfortherapeuticintervention
AT franciscolucianohonoriobarretocavalcante polyneuropathyincerebrotendinousxanthomatosisdiagnosticchallengesandpotentialfortherapeuticintervention
AT oliverreiksmiyajima polyneuropathyincerebrotendinousxanthomatosisdiagnosticchallengesandpotentialfortherapeuticintervention
AT carolinafigueiredosantos polyneuropathyincerebrotendinousxanthomatosisdiagnosticchallengesandpotentialfortherapeuticintervention
AT rodrigofagundesdarosa polyneuropathyincerebrotendinousxanthomatosisdiagnosticchallengesandpotentialfortherapeuticintervention
AT andreluizsantospessoa polyneuropathyincerebrotendinousxanthomatosisdiagnosticchallengesandpotentialfortherapeuticintervention
AT pedrobraganeto polyneuropathyincerebrotendinousxanthomatosisdiagnosticchallengesandpotentialfortherapeuticintervention
AT pauloribeironobrega polyneuropathyincerebrotendinousxanthomatosisdiagnosticchallengesandpotentialfortherapeuticintervention